Dr. Qiwei W. Gai
Claim this profileWilliam E Kahlert Regional Cancer Center/Sinai Hospital
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
9 reported clinical trials
17 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Qiwei W. Gai is currently running
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Qiwei W. Gai
Clinical Trial Related2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Qiwei W. Gai has experience with
- Pembrolizumab
- Biospecimen Collection
- Carboplatin
- Paclitaxel
- Questionnaire Administration
- Crizotinib
Breakdown of trials Qiwei W. Gai has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Qiwei W. Gai specialize in?
Qiwei W. Gai focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Qiwei W. Gai currently recruiting for clinical trials?
Yes, Qiwei W. Gai is currently recruiting for 6 clinical trials in Westminster Maryland. If you're interested in participating, you should apply.
Are there any treatments that Qiwei W. Gai has studied deeply?
Yes, Qiwei W. Gai has studied treatments such as Pembrolizumab, Biospecimen Collection, Carboplatin.
What is the best way to schedule an appointment with Qiwei W. Gai?
Apply for one of the trials that Qiwei W. Gai is conducting.
What is the office address of Qiwei W. Gai?
The office of Qiwei W. Gai is located at: William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster, Maryland 21157 United States. This is the address for their practice at the William E Kahlert Regional Cancer Center/Sinai Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.